Bullish option flow detected in BridgeBio Pharma with 2,899 calls trading, 1.7x expected, and implied vol increasing over 2 points to 58.60%. Jan-25 30 calls and Jan-25 35 calls are the most active options, with total volume in those strikes near 1,800 contracts. The Put/Call Ratio is 0.01. Earnings are expected on October 31st.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBIO:
- BridgeBio presenting results of Phase 3 study of acoramidis in ATTR-CM
- BridgeBio initiated with a Perform at Oppenheimer
- BridgeBio completes enrollment of FORTIFY Phase 3 study of BBP-418
- Opening Day: Obesity drug developer BioAge makes Nasdaq debut
- BridgeBio presents post-hoc analysis evaluating acoramidis